Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Protagonist Therapeutics Inc buy BTIG Research

Start price
€21.80
16:30 / 50%
Target price
€46.93
24.07.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.07.25. The prediction end date can be changed by BTIG_Research at any time.
Performance without dividends (%)
Name 1w
Protagonist Therapeutics Inc -
iShares Core DAX® -0.116%
iShares Nasdaq 100 -2.733%
iShares Nikkei 225® -1.721%
iShares S&P 500 -1.527%

Comments by BTIG_Research for this prediction

In the thread Protagonist Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 46.925
Change
Ends at 24.07.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat